What is RWD?
Use of data from routine clinical practice and post-market surveillance to inform regulatory decisions on chemicals, pharmaceuticals, and health interventions.
Real-World Data (RWD)
Use of data from routine clinical practice and post-market surveillance to inform regulatory decisions on chemicals, pharmaceuticals, and health interventions.
See current Real-World Data (RWD) activity, then check whether the developments map to your products, sites, suppliers, markets, and internal owners.
Book a demo
Prefer to self-diagnose first? Get a free exposure assessment
Current activity
Steady
In line with the prior 8-week baseline
3-month trend
32 alerts tracked
Updated 5 August 2026, 14:38
Topic context
How to read RWD regulatory activity
Why it matters
RWD developments can change product scope, supplier expectations, market access, reporting duties, and risk ownership. Foresight tracks the signals early so teams can respond before obligations become urgent.
How Foresight monitors it
Foresight monitors official sources, extracts structured regulatory intelligence, and maps alerts to a customer's products, substances, markets, and priorities so teams see the relevant signal with source evidence for review.
Frequently asked questions
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Join 3,500+ professionals staying ahead
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at
